Pharmacology

mood disorder, suicide, lithium, unipolar depression, self-harm, guideline-based medication, myocardial infarction, oldest-old, vancomycin-resistant Enterococci, VRE, bacterial transmission

mood disorder, suicide, lithium, unipolar depression, self-harm, guideline-based medication, myocardial infarction, oldest-old, vancomycin-resistant Enterococci, VRE, bacterial transmission

mood disorder, suicide, lithium, unipolar depression, self-harm, guideline-based medication, myocardial infarction, oldest-old, vancomycin-resistant Enterococci, VRE, bacterial transmission

antimicrobial drug, overweight, obesity, weight and dosage, linezolid, vancomycin, complicated skin and skin structure infections, nosocomial pneumonia

antimicrobial drug, overweight, obesity, weight and dosage, linezolid, vancomycin, complicated skin and skin structure infections, nosocomial pneumonia

antimicrobial drug, overweight, obesity, weight and dosage, linezolid, vancomycin, complicated skin and skin structure infections, nosocomial pneumonia

acute hepatitis, dietary supplement, fulminant liver failure

acute hepatitis, dietary supplement, fulminant liver failure

acute hepatitis, dietary supplement, fulminant liver failure

diabetes and coronary artery disease, percutaneous coronary intervention, coronary artery bypass graft, surgical site infections, chlorhexidine

diabetes and coronary artery disease, percutaneous coronary intervention, coronary artery bypass graft, surgical site infections, chlorhexidine

diabetes and coronary artery disease, percutaneous coronary intervention, coronary artery bypass graft, surgical site infections, chlorhexidine

allogeneic blood transfusion, intravenous iron therapy, IV iron

allogeneic blood transfusion, intravenous iron therapy, IV iron

allogeneic blood transfusion, intravenous iron therapy, IV iron

fluoroquinolones, kidney damage, acute kidney injury, renal failure, acute interstitial nephritis

fluoroquinolones, kidney damage, acute kidney injury, renal failure, acute interstitial nephritis

fluoroquinolones, kidney damage, acute kidney injury, renal failure, acute interstitial nephritis

communication barriers, limited proficiency in English, limited English proficient

communication barriers, limited proficiency in English, limited English proficient

communication barriers, limited proficiency in English, limited English proficient

sitagliptin, dipeptidyl peptidase-4 inhibitor, DPP-4 inhibitor, cardiovascular risk factors, Staphylococcus aureus, S aureus, methicillin-resistant staphylococcus aureus, Assessment of Telavancin for Treatment of Hospital Acquired Pneumonia, streptococcus pneumoniae, menopause, vasomotor symptoms, hot flashes, paroxetine

sitagliptin, dipeptidyl peptidase-4 inhibitor, DPP-4 inhibitor, cardiovascular risk factors, Staphylococcus aureus, S aureus, methicillin-resistant staphylococcus aureus, Assessment of Telavancin for Treatment of Hospital Acquired Pneumonia, streptococcus pneumoniae, menopause, vasomotor symptoms, hot flashes, paroxetine

sitagliptin, dipeptidyl peptidase-4 inhibitor, DPP-4 inhibitor, cardiovascular risk factors, Staphylococcus aureus, S aureus, methicillin-resistant staphylococcus aureus, Assessment of Telavancin for Treatment of Hospital Acquired Pneumonia, streptococcus pneumoniae, menopause, vasomotor symptoms, hot flashes, paroxetine

placebo, placebo effect, patient trust

placebo, placebo effect, patient trust

placebo, placebo effect, patient trust